🇺🇸 FDA
Patent

US 7557138

5-phenoxyalkoxypsoralens and methods for selective inhibition of the voltage gated Kv1.3 potassium channel

granted A61PA61P1/04A61P1/16

Quick answer

US patent 7557138 (5-phenoxyalkoxypsoralens and methods for selective inhibition of the voltage gated Kv1.3 potassium channel) held by The Regents of the University of California expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
122
CPC classes
A61P, A61P1/04, A61P1/16, A61P15/00, A61P17/00